Title : Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer.

Pub. Date : 2020 Dec

PMID : 33096154






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Accordingly, several studies on combining glucose transporter (GLUT) inhibitors with chemotherapeutic agents, such as doxorubicin, paclitaxel, and cytarabine, showed synergistic or additive anticancer effects, reduced chemo-, radio-, and immuno-resistance, and reduced toxicity due to lowering the therapeutic doses required for desired chemotherapeutic effects, as compared with monotherapy. Doxorubicin solute carrier family 2 member 1 Homo sapiens
2 Accordingly, several studies on combining glucose transporter (GLUT) inhibitors with chemotherapeutic agents, such as doxorubicin, paclitaxel, and cytarabine, showed synergistic or additive anticancer effects, reduced chemo-, radio-, and immuno-resistance, and reduced toxicity due to lowering the therapeutic doses required for desired chemotherapeutic effects, as compared with monotherapy. Doxorubicin solute carrier family 2 member 1 Homo sapiens